Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.
4 November 2022
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.
20 April 2021
A call to arms has gone out to Queenslanders aged 56 and over to help advance The University of Queensland’s COVID-19 vaccine project.
27 August 2020
Developing early and improved diagnostic tests to lift ovarian cancer survival rates are the focus of two research projects commencing at The University of Queensland.
25 May 2020
The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
29 April 2020
The University of Queensland’s potential COVID-19 vaccine is entering an important new phase of testing with the live coronavirus to determine how effectively it induces protection against coronavirus infection.
9 April 2020
A process developed by University of Queensland researchers to produce larger quantities of the Hendra virus therapeutic antibody could be expanded to manufacture treatments for other potentially deadly viruses around the world.
4 February 2020
A potential therapy targeting difficult-to-treat immune system disorders such as rheumatoid arthritis will progress to clinical trials next year after securing $20 million in Series A funding.
1 November 2019
Staff who have contributed to The University of Queensland’s vision of excellence have been celebrated and awarded at the 2016 UQ Awards for Excellence.
10 June 2016University of Queensland researchers have produced batches of a monoclonal antibody, which may offer hope as a potential therapeutic for Hendra virus infection in humans
12 July 2011
Australian researchers aim to use a newly-funded collaboration to develop a new generation of cancer treatment, “supercharging” antibodies with a drug delivery vehicle for targeting tumours.
10 July 2011
